Johnson & Johnson (JNJ) has 20 已知的內部人和機構持有人紀錄. 最大持有人為 McEvoy Ashley 持有 52,038 股. 其他重要持有人包括 Washington A. Eugene 和 WILLIAMS RONALD A.
過去12個月，內部人進行了 75 筆交易，涉及 JNJ 股票 — 32 筆買入 (價值為 $257.69K) 和 6 筆賣出 (價值為 $20.51M). 內部人買入超過賣出，可能表明對公司前景有信心.
JNJ 內部人持股
最大持股人
McEvoy Ashley
52,038 股
主要內部人持股
| # |
姓名 |
職位 |
持股數量 |
最近申報日期 |
相對規模 |
| 1 |
Mcevoy Ashley |
EVP, Ww Chair, Medtech |
52,038 |
2023-08-25 |
|
| 2 |
Washington A. Eugene |
Director |
28,569 |
2023-03-09 |
|
| 3 |
Williams Ronald A |
Director |
25,673 |
2022-02-17 |
|
| 4 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
25,447 |
2026-02-23 |
|
| 5 |
Prince Charles |
Director |
24,824 |
2022-02-17 |
|
| 6 |
Mulcahy Anne M |
Director |
21,471 |
2024-04-29 |
|
| 7 |
Mcclellan Mark B. |
Director |
19,755 |
2025-04-28 |
|
| 8 |
Davis Ian |
Director |
17,706 |
2022-02-17 |
|
| 9 |
Davis D Scott |
Director |
15,604 |
2024-10-15 |
|
| 10 |
Beckerle Mary C |
Director |
15,395 |
2025-04-28 |
|
| 11 |
Hewson Marillyn A |
Director |
14,306 |
2026-03-12 |
|
| 12 |
Gorsky Alex |
Director |
11,047 |
2022-02-17 |
|
| 13 |
Weinberger Mark A |
Director |
10,737 |
2025-04-28 |
|
| 14 |
Doudna Jennifer A |
Director |
9,656 |
2025-04-28 |
|
| 15 |
Joly Hubert |
Director |
7,987 |
2025-04-28 |
|
| 16 |
West Nadja |
Director |
6,573 |
2025-04-28 |
|
| 17 |
Woods Eugene A. |
Director |
5,240 |
2026-03-12 |
|
| 18 |
Johnson Paula A |
Director |
4,266 |
2025-04-28 |
|
| 19 |
Mammen Mathai |
EVP, Pharm, R&d |
3,922 |
2022-02-17 |
|
| 20 |
Adamczyk Darius |
Director |
3,713 |
2024-04-29 |
|
近期交易 (過去12個月)
| 日期 |
姓名 |
職位 |
類型 |
股數 |
股價 |
總價值 |
| 2026-03-10 |
Woods Eugene A. |
Director |
限制性股票授予 (RSU) |
155 |
- |
- |
| 2026-03-10 |
Pinto Daniel E |
Director |
限制性股票授予 (RSU) |
129 |
- |
- |
| 2026-03-10 |
Hewson Marillyn A |
Director |
限制性股票授予 (RSU) |
206 |
- |
- |
| 2025-03-04 |
Hewson Marillyn A |
Director |
限制性股票授予 (RSU) |
75 |
- |
- |
| 2026-02-27 |
Decker Robert J |
VP Corporate Controller |
期權行權（賣出） |
4,075 |
$115.67 |
$471.36K |
| 2026-02-20 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
知情賣出 |
1,322 |
$245.66 |
$324.76K |
| 2026-02-15 |
Mulholland Kristen |
EVP, Chief HR Officer |
期權行權（賣出） |
419 |
- |
- |
| 2026-02-13 |
Mulholland Kristen |
EVP, Chief HR Officer |
期權行權（賣出） |
410 |
- |
- |
| 2026-02-18 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
期權行權（賣出） |
13,625 |
$115.67 |
$1.58M |
| 2026-02-15 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
期權行權（賣出） |
1,028 |
- |
- |
| 2026-02-13 |
Schmid Timothy |
EVP, Ww Chair, Medtech |
期權行權（賣出） |
4,378 |
- |
- |
| 2026-02-15 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
期權行權（賣出） |
961 |
- |
- |
| 2026-02-13 |
Forminard Elizabeth |
EVP, Chief Legal Officer |
期權行權（賣出） |
651 |
- |
- |
| 2026-02-17 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
知情賣出 |
6,197 |
$243.39 |
$1.51M |
| 2026-02-15 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
期權行權（賣出） |
492 |
- |
- |
| 2026-02-13 |
Broadhurst Vanessa |
EVP, Global Corp Affairs |
期權行權（賣出） |
408 |
- |
- |
| 2026-02-17 |
Swanson James D. |
EVP, CIO |
期權行權（賣出） |
20,521 |
$164.62 |
$3.38M |
| 2026-02-15 |
Swanson James D. |
EVP, CIO |
期權行權（賣出） |
492 |
- |
- |
| 2026-02-13 |
Swanson James D. |
EVP, CIO |
期權行權（賣出） |
19,368 |
$165.89 |
$3.21M |
| 2026-02-15 |
Decker Robert J |
VP Corporate Controller |
期權行權（賣出） |
339 |
- |
- |
| 2026-02-13 |
Decker Robert J |
VP Corporate Controller |
期權行權（賣出） |
312 |
- |
- |
| 2026-02-15 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
期權行權（賣出） |
606 |
- |
- |
| 2026-02-13 |
Wengel Kathryn E |
EVP, Chief To and Risk Officer |
期權行權（賣出） |
13,706 |
- |
- |
| 2026-02-15 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
期權行權（賣出） |
1,594 |
- |
- |
| 2026-02-13 |
Taubert Jennifer L |
EVP, Wwc. Innovative Medicine |
期權行權（賣出） |
1,302 |
- |
- |
